ALS and Motor Neuron Disease
USMLE Step 1 trap: Fails to recognize that ALS requires concurrent UMN and LMN signs in the same patient. ALS is defined by the simultaneous presence of both UMN signs (spasticity, hyperreflexia, Babinski) and LMN signs (fasciculations, atrophy, weakness) in the same patient.
ALS is the prototypical combined upper and lower motor neuron disease, and USMLE Step 1 loves testing it precisely because it requires you to hold two seemingly contradictory findings in your head at once — hyperreflexia alongside atrophy, spasticity alongside fasciculations. The pathology involves degeneration of both the corticospinal tracts (UMN) and anterior horn cells (LMN), which is why you see signs from both levels simultaneously. The SOD1 mutation accounts for a familial subset (~20% of familial cases), and riluzole (a glutamate release inhibitor) is the classic disease-modifying agent to know.
The exam tests ALS from three main angles: recognizing the combined UMN/LMN picture in a clinical vignette, identifying what is specifically spared (sensory, bowel/bladder, extraocular movements), and distinguishing ALS from related motor neuron diseases like SMA, polio, and post-polio syndrome. Passage-based questions often describe a middle-aged patient with a mix of fasciculations and brisk reflexes — the trap is thinking these can't coexist. They absolutely can in ALS, and that combination is essentially diagnostic.
The trickiest part is the differential. SMA is pure LMN, so no hyperreflexia, no Babinski — and it's caused by SMN1 deletion, not SOD1. Polio is also pure LMN but has a viral prodrome and asymmetric flaccid paralysis. If a vignette mentions sensory loss alongside motor deficits, ALS is off the table — that's your signal to think about something else entirely. Nailing these distinctions is how you score on USMLE Step 1 motor neuron questions.
Common misconceptions
What the exam tests
- Identify which spinal cord tracts and cell populations are affected in ALS, and recognize that the SOD1 mutation defines the major familial genetic subset.
- Recognize the simultaneous presence of both UMN signs (spasticity, hyperreflexia, upgoing Babinski) and LMN signs (fasciculations, muscle atrophy, flaccid weakness) as the defining clinical picture of ALS — and know what is specifically spared: sensation, bowel/bladder function, and extraocular movements.
- Distinguish ALS from other motor neuron diseases in a vignette: SMA (pure LMN, SMN1 deletion, pediatric onset), polio (pure LMN, asymmetric, post-viral), and post-polio syndrome (late-onset LMN decline after prior polio infection).
Can you avoid these mistakes?
Related topics
See how your Anki deck covers this topic.
Upload your deck for a free audit →